Struggling to find Hadlima at your pharmacy? Learn why this adalimumab biosimilar can be hard to locate and what steps you can take to get it in 2026.
You've got your prescription for Hadlima in hand, but when you call your pharmacy, the answer is the same: "We don't have it in stock." Maybe they've never even heard of it. You're not imagining things — finding Hadlima can be genuinely difficult, even though it's FDA-approved and widely covered by insurance.
Hadlima is a biosimilar to Humira (Adalimumab), one of the most prescribed biologic medications in the world. It treats conditions like rheumatoid arthritis, Crohn's disease, psoriasis, and more. But being available on paper doesn't always mean it's sitting on pharmacy shelves.
In this article, we'll explain exactly why Hadlima is so hard to find, what's behind the supply issues, and — most importantly — what you can do about it right now.
Hadlima (Adalimumab-bwwd) is a biologic medication made by Organon LLC. It's a biosimilar to Humira, meaning it works the same way as Humira and has been shown to be just as safe and effective. The FDA approved Hadlima in 2019, and it became available in the United States in July 2023.
Hadlima is a TNF (tumor necrosis factor) blocker. It works by binding to TNF-alpha, a protein that causes inflammation in the body. By blocking TNF-alpha, Hadlima helps reduce symptoms of autoimmune conditions including:
Hadlima is given as a subcutaneous injection (a shot under the skin), typically every other week. It comes as a prefilled syringe or an autoinjector called Hadlima PushTouch. To learn more about how this medication works, check out our guide on how Hadlima works.
There are several reasons why patients struggle to fill their Hadlima prescriptions. Here are the main ones:
Most retail pharmacies — including major chains like CVS, Walgreens, and Rite Aid — have carried Humira for years. When a doctor writes a prescription for Hadlima instead, many pharmacies simply don't have it on their shelves. Unlike generic pills, biosimilars can't be automatically substituted for the brand-name biologic. The pharmacy has to specifically order Hadlima, which can take days.
Because biosimilars are relatively new to the market (Hadlima only launched in mid-2023), many pharmacies haven't added them to their regular inventory. This is especially true for smaller or rural pharmacies that carry fewer specialty medications.
Even when your insurance covers Hadlima, the process to get it approved can be complicated. Most insurance plans require prior authorization for biologic medications. Some plans use step therapy, meaning you may need to try other treatments first. And depending on your plan, Hadlima might be covered under the pharmacy benefit or the medical benefit — each with different rules.
This back-and-forth between your doctor, insurance company, and pharmacy creates delays. Some patients wait weeks just to get approval, and by then, the pharmacy may need to reorder the medication.
Many insurance plans require that biologic medications like Hadlima be filled through a specialty pharmacy rather than your local retail pharmacy. Specialty pharmacies handle high-cost medications and often ship them directly to your home. But if your doctor sends the prescription to a regular pharmacy, you might be told they can't fill it — not because it's unavailable, but because your insurance won't cover it there.
If you're not sure where your insurance wants you to fill Hadlima, call the number on the back of your insurance card and ask about specialty pharmacy requirements.
Hadlima entered a crowded biosimilar market. There are now multiple Adalimumab biosimilars available, including Amjevita, Hyrimoz, and Cyltezo. Pharmacies and insurance plans are still figuring out which biosimilars to stock and prefer. Some plans favor one biosimilar over another based on pricing contracts, which means Hadlima may not be the preferred option on every formulary.
This competition is actually good for patients in the long run — it drives prices down. But in the short term, it means any single biosimilar, including Hadlima, may be harder to find at a given pharmacy.
The good news is that Hadlima is available — you just might need to look in the right places. Here's what to do:
The fastest way to find Hadlima near you is to use Medfinder. Medfinder lets you search for medications and see which pharmacies in your area have them in stock. It's free to use and saves you from calling pharmacy after pharmacy.
If your retail pharmacy can't get Hadlima, ask your doctor or insurance company about approved specialty pharmacies. Many specialty pharmacies ship medications directly to your home with free delivery, and they often have dedicated support teams to help with insurance paperwork.
Organon, the maker of Hadlima, offers a $0 co-pay savings card for eligible commercially insured patients. They also have a patient support program that can help you find a pharmacy that carries Hadlima and assist with insurance issues. Visit hadlima.com for more information.
If you've been trying to find Hadlima without success, your doctor may be able to switch you to another Adalimumab biosimilar that's more readily available on your insurance plan. Options include Amjevita, Hyrimoz, or Cyltezo. Check out our full guide on alternatives to Hadlima for more details.
Independent and compounding pharmacies are sometimes more willing to special-order medications like Hadlima. They may also offer more personalized service to help you navigate insurance requirements. For tips on finding pharmacies that stock Hadlima, read our article on how to find Hadlima in stock near you.
One of Hadlima's biggest advantages is its price. The wholesale acquisition cost (WAC) for Hadlima is approximately $1,038 per carton, compared to Humira's WAC of about $6,922 per carton. That's roughly 85% less expensive.
However, what you actually pay depends on your insurance coverage, deductible, and co-pay. With Organon's $0 co-pay savings card, many commercially insured patients pay nothing out of pocket. For more ways to save, see our guide on how to save money on Hadlima.
Finding Hadlima can be frustrating, but the challenges are mostly logistical — not medical. The medication is FDA-approved, widely covered by insurance, and significantly more affordable than Humira. The main barriers are pharmacy stocking practices, insurance requirements, and the fact that the biosimilar market is still maturing.
If you're struggling to find Hadlima, don't give up. Use tools like Medfinder to check pharmacy availability, ask about specialty pharmacy options, and work with your doctor to find the best path forward. You have options, and you deserve access to the medication your doctor prescribed.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
